This study is currently not recruiting participants.

Unexpected high rate of early tumor recurrence in patients with Hepatitis C virus (HCV)-related Hepatocellular Carcinoma (HCC) undergoing interferon (IFN)-free therapy

  • STATUS
    Not Recruiting
Send
Updated on 19 February 2024

Summary

The purpose of this study is to characterize the association between IFN (Interfereon)-free DAA (Direct Acting Antiviral) HCV (Hepatits-C Virus) therapy and HCC (Heaptocellular Carcinoma) recurrence rates and time-to-recurrence among HCC patients with complete response across ~30 centers in North America.

Description

The purpose of this study is to characterize the association between IFN (Interfereon)-free DAA (Direct Acting Antiviral) HCV (Hepatits-C Virus) therapy and HCC (Heaptocellular Carcinoma) recurrence rates and time-to-recurrence among HCC patients with complete response across ~30 centers in North America.

Details
Condition cirrhosis,hepatitis C
Age 100years or below
Clinical Study IdentifierTX6967
Last Modified on19 February 2024

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.